<DOC>
	<DOCNO>NCT01035437</DOCNO>
	<brief_summary>This study aim find effect capecitabine , oxaliplatin radiation therapy follow photodynamic therapy esophageal cancer .</brief_summary>
	<brief_title>Study Determination Feasibility Toxicity Pre-Treatment With HPPH ( 2-11-Hexyloxyethyl-2 Devinyl Pyropheophorbide-a ) Photodynamic Therapy Prior Chemoradiation Non-Operable Patients With Obstructive Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Partially completely obstruct primary esophageal carcinoma , clinical stage IIVa determine endoscopy , CTscan , PET +/ endoscopic ultrasound . For distal esophagus tumor involve GE junction , least 50 % great tumor bulk distal esophagus Ineligible refuse surgical resection No Prior therapy allow esophageal cancer ECOG Performance status 01 Life expectancy &gt; 4 month Adequate hematologic parameter ( hemoglobin &gt; 9g/dl , ANC &gt; 1500/ul , Platelets &gt; 100,000/ul ) Adequate biochemical parameter ( total bilirubin creatinine within institutional limit , AST alkaline phosphatase less tham equal 3xUNL ) Age &gt; 18 year Signed informed consent Bronchoscopy biopsy cytology primary esophageal cancer &lt; 26 cm incisor Female patient childbearing potential negative serum urine pregnancy test within 7 day prior registration Patients Childbearing potential agree use effective form contraception study 90 day follow last dose study medication ( effective form contraception oral contraceptive double barrier method Both men woman member race ethnic eligible trial Hypersensitivity platinum compound , fluoropyrimidines antiemetic appropriate administration conjunction protocoldirected chemotherapy Patients may receive investigational agent Patients know brain metastasis exclude trail Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia psychiatric illness/social situation would limit compliance study requirement Peripheral neuropathy â‰¥ Grade 2 History second malignancy within previous year except curatively treat carcinoma cervix insitu nonmelanomatous skin cancer Patients pregnant lactate Porphyria hypersensitivity porphyrinlike compound Patients know HIV Hepatitis B C ( active , previously treat ) Patients tracheal bronchial involvement , determine bronchoscopy Patients document unilateral bilateral vocal cord paralysis Patients T4 lesion CT , MRI EUS involve aorta , lung pericardium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>obstruct</keyword>
</DOC>